Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Macromolecular Bioscience|December 14, 2011
Photocrosslinked co-networks from glycidylmethacrylated gelatin and poly(ethylene glycol) methacrylatesBenjamin F Pierce, Giuseppe Tronci, Martin Rössle, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 21, 2017
Rapid change of liver stiffness after variceal ligation and TIPS implantationFelix Piecha, Daniel Paech, Janina Sollors, et al.
Cardiovascular and Interventional Radiology|February 22, 2019
Adjuvant Transjugular Variceal Occlusion at Creation of a Transjugular Intrahepatic Portosystemic Shunt (TIPS): Efficacy and Risks of Bucrylate EmbolizationMichael Schultheiß, Max Giesler, Lars Maruschke, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2021
Glecaprevir/pibrentasvir for 8 weeks in patients with compensated cirrhosis: Safety and effectiveness data from the German Hepatitis C-RegistryHartwig Klinker, Uwe Naumann, Martin Rössle, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 8, 2002
Human insulin release processes measured by intraportal samplingNiels Pørksen, Thorbjørn Grøfte, Jacob Greisen, et al.
European Radiology|April 9, 2015
Effect of TIPS placement on portal and splanchnic arterial blood flow in 4-dimensional flow MRIZoran Stankovic, Martin Rössle, Wulf Euringer, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trialUlrich F H Leuschner, Birgit Lindenthal, Günter Herrmann, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 4, 2019
Smaller-Diameter Covered Transjugular Intrahepatic Portosystemic Shunt Stents Are Associated With Increased SurvivalJonel Trebicka, Diana Bastgen, Jonathan Byrtus, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 9, 2014
The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-studyWolfgang Kreisel, Peter Deibert, Limas Kupcinskas, et al.
Pageof 4